PMC:7228307 / 1545-1828
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 16 | 209-216 | Gene | denotes | FcγRIIb | Gene:2213 |
| 18 | 255-259 | Gene | denotes | FcγR | Gene:2213 |
| 25 | 48-54 | Chemical | denotes | glycan | MESH:D011134 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T8 | 58-65 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T18 | 40-47 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focused |
| T19 | 85-87 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T20 | 174-184 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activating |
| T21 | 185-187 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T22 | 188-190 | http://purl.obolibrary.org/obo/CLO_0008882 | denotes | Rs |
| T23 | 209-211 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T24 | 255-257 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T6 | 58-65 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T2 | 58-65 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 16 | 209-216 | Gene | denotes | FcγRIIb | Gene:2213 |
| 18 | 255-259 | Gene | denotes | FcγR | Gene:2213 |
| 25 | 48-54 | Chemical | denotes | glycan | MESH:D011134 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T12 | 0-283 | Sentence | denotes | Such development strategies now include focused glycan or protein engineering of the Fc to increase affinity and/or tailor specificity for selective engagement of individual activating FcγRs or the inhibitory FcγRIIb or alternatively, for the ablation of FcγR interaction altogether. |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T8 | 58-65 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T12 | 0-283 | Sentence | denotes | Such development strategies now include focused glycan or protein engineering of the Fc to increase affinity and/or tailor specificity for selective engagement of individual activating FcγRs or the inhibitory FcγRIIb or alternatively, for the ablation of FcγR interaction altogether. |